These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30744630)

  • 21. Comorbidities and COPD severity in a clinic-based cohort.
    Raherison C; Ouaalaya EH; Bernady A; Casteigt J; Nocent-Eijnani C; Falque L; Le Guillou F; Nguyen L; Ozier A; Molimard M
    BMC Pulm Med; 2018 Jul; 18(1):117. PubMed ID: 30012144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Risk Factors and Characteristics of COPD Among Nonsmokers in Korea: An Analysis of KNHANES IV and V.
    Lee SH; Hwang ED; Lim JE; Moon S; Kang YA; Jung JY; Park MS; Kim SK; Chang J; Kim YS; Kim SY
    Lung; 2016 Jun; 194(3):353-61. PubMed ID: 27038474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of depression and its risk factors in patients with chronic obstructive pulmonary disease.
    Negi H; Sarkar M; Raval AD; Pandey K; Das P
    Indian J Med Res; 2014 Mar; 139(3):402-8. PubMed ID: 24820834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease.
    Steveling EH; Clarenbach CF; Miedinger D; Enz C; Dürr S; Maier S; Sievi N; Zogg S; Leuppi JD; Kohler M
    Respiration; 2014; 88(6):451-7. PubMed ID: 25472034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of coronary atherosclerosis in patients with COPD.
    Dursunoglu N; Dursunoglu D; Yıldız Aİ; Uludag B; Alaçam ZN; Sarıçopur A
    Clin Respir J; 2017 Nov; 11(6):751-756. PubMed ID: 26605517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAT score single item analysis in patients with COPD: Results from COSYCONET.
    Marietta von Siemens S; Alter P; Lutter JI; Kauczor HU; Jobst B; Bals R; Trudzinski FC; Söhler S; Behr J; Watz H; Waschki B; Bewig B; Jones PW; Welte T; Vogelmeier CF; Jörres RA; Kahnert K; ;
    Respir Med; 2019 Nov; 159():105810. PubMed ID: 31739262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COPD in Taiwan: a National Epidemiology Survey.
    Cheng SL; Chan MC; Wang CC; Lin CH; Wang HC; Hsu JY; Hang LW; Chang CJ; Perng DW; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2459-67. PubMed ID: 26648708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
    Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of thoracic pain in patients with chronic obstructive pulmonary disease and relationship with patient characteristics: a cross-sectional observational study.
    Janssen DJ; Wouters EF; Parra YL; Stakenborg K; Franssen FM
    BMC Pulm Med; 2016 Apr; 16():47. PubMed ID: 27052199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
    Kahnert K; Lucke T; Huber RM; Behr J; Biertz F; Vogt A; Watz H; Alter P; Fähndrich S; Bals R; Holle R; Karrasch S; Söhler S; Wacker M; Ficker JH; Parhofer KG; Vogelmeier C; Jörres RA;
    PLoS One; 2017; 12(5):e0177501. PubMed ID: 28505167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a case-control study.
    Xiang YT; Wong TS; Tsoh J; Ungvari GS; Correll CU; Sareen J; Penner-Goeke K; Ko FW; Hui DS; Chiu HF
    Perspect Psychiatr Care; 2015 Apr; 51(2):121-7. PubMed ID: 24890904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.
    Kumbhare S; Pleasants R; Ohar JA; Strange C
    Ann Am Thorac Soc; 2016 Jun; 13(6):803-10. PubMed ID: 26974689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiety and depression among dairy farmers: the impact of COPD.
    Guillien A; Laurent L; Soumagne T; Puyraveau M; Laplante JJ; Andujar P; Annesi-Maesano I; Roche N; Degano B; Dalphin JC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1-9. PubMed ID: 29296078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of the relationship between chronic obstructive pulmonary disease, smoking and depression in an integrated healthcare system.
    Riblet NB; Gottlieb DJ; Hoyt JE; Watts BV; Shiner B
    Gen Hosp Psychiatry; 2020; 64():72-79. PubMed ID: 32279024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in health status in COPD: a seven-year follow-up cohort study.
    Sundh J; Montgomery S; Hasselgren M; Kämpe M; Janson C; Ställberg B; Lisspers K
    NPJ Prim Care Respir Med; 2016 Oct; 26():16073. PubMed ID: 27763623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interrelations among aspects of dyspnea and symptoms of depression in COPD patients - a network analysis.
    Schuler M; Wittmann M; Faller H; Schultz K
    J Affect Disord; 2018 Nov; 240():33-40. PubMed ID: 30048834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET].
    Jörres RA; Welte T; Bals R; Koch A; Schnoor M; Vogelmeier C
    Dtsch Med Wochenschr; 2010 Mar; 135(10):446-9. PubMed ID: 20198540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of chronic kidney disease in chronic obstructive pulmonary disease.
    Trudzinski FC; Alqudrah M; Omlor A; Zewinger S; Fliser D; Speer T; Seiler F; Biertz F; Koch A; Vogelmeier C; Welte T; Watz H; Waschki B; Fähndrich S; Jörres R; Bals R;
    Respir Res; 2019 Jul; 20(1):151. PubMed ID: 31299972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.